Direct Evidence for Caution with Single Antiplatelet Therapy Added to Full Dose Anticoagulation for Patients Undergoing Intervention for Lower Extremity Arterial Disease

Eur J Vasc Endovasc Surg. 2024 Oct;68(4):508-509. doi: 10.1016/j.ejvs.2024.05.039. Epub 2024 May 29.

Authors

Christopher P Twine¹, Stavros K Kakkos²

Affiliations

¹ North Bristol NHS Trust and University of Bristol, Bristol, UK. Electronic address: Christopher.twine@bristol.ac.uk.
² Department of Vascular Surgery, University Hospital of Patras, Patras, Greece.

PMID: 38821348
DOI: 10.1016/j.ejvs.2024.05.039

No abstract available

Keywords: Antiplatelet agents; Percutaneous coronary angioplasty; Peripheral arterial disease; Transluminal angioplasty.

MeSH terms

Anticoagulants* / administration & dosage
Anticoagulants* / adverse effects
Drug Therapy, Combination
Endovascular Procedures / adverse effects
Hemorrhage / chemically induced
Humans
Lower Extremity* / blood supply
Peripheral Arterial Disease* / drug therapy
Platelet Aggregation Inhibitors* / administration & dosage
Platelet Aggregation Inhibitors* / adverse effects
Treatment Outcome

Substances

Platelet Aggregation Inhibitors
Anticoagulants